Y-Intercept (HK)’s Molecular Templates, Inc. MTEM Stock Holding History

Y-Intercept (HK)’s Portfolio MTEM Stock Details MTEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-915	Closed	-$13K	–	1361
2022 Q2	$13K	Buy	+915	New	+$21.4K	﹤0.01%	807

Other funds holding MTEM

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Y-Intercept (HK)'s MTEM Position: Q3 2022 in Review

Y-Intercept (HK) sold out of Molecular Templates, Inc. (MTEM) in Q3 2022, closing a stake of 915 shares — an estimated $13K sold.

Y-Intercept (HK) first reported a position in MTEM in Q2 2022 and held it in 1 quarter. The position peaked at $13K in Q2 2022. 58 funds tracked by Wall St. Rank hold MTEM as of Q3 2022.

Y-Intercept (HK) reported no remaining Molecular Templates, Inc. position as of Q3 2022 after selling out during the quarter.
Y-Intercept (HK) sold 915 Molecular Templates, Inc. shares in Q3 2022, an estimated $13K.
Y-Intercept (HK) first reported a position in Molecular Templates, Inc. in Q2 2022 and held it in 1 quarter.
Y-Intercept (HK)'s Molecular Templates, Inc. position peaked at $13K in Q2 2022.
58 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2022.

Based on Y-Intercept (HK)'s 13F filing for Q3 2022, filed 14 Feb 2023.